Immunopathology of TB: Studying the role of the lymph nodes in the TB spectrum.
Researchers working on a novel study of the lymph nodes of humans discuss this complex project which is studying lymph node immunology, and the role of these organs in the progression to TB disease with a Wellcome Leap grant.
Professor Mark Hatherill addresses United Nations High-level Meeting on Tuberculosis
SEPTEMBER 2023: Prof Mark Hatherill, addressed the UN High-level Meeting on Tuberculosis, calling for a quantum jump in TB vaccine research and development (R&D) funding, to deliver the transformative tools needed to end the TB pandemic.
Titan Vaccine Research Project
Dr Munyaradzi Musvosvi speaks about the Titan Vaccine Research Project which will allow the selection of the most promising TB vaccine candidates.
Phase 1b/2a clinical trial in adults of novel TB vaccine candidate MTBVAC shows promising results.
Findings from the IAVI A-050 study, published in Lancet Global Health, demonstrate that vaccination with MTBVAC caused similar or stronger immune responses compared to the BCG vaccine in adults, of MTBVAC were as safe as BCG.
Narrative history of the South African Tuberculosis Vaccine Initiative
A narrative history of the South African Tuberculosis Vaccine Initiative as told through the voices of the many people who were involved in setting up and sustaining the organisation from 2001 to the present.
News from the South African Tuberculosis Vaccine Initiative.
Opinion piece: The hunt for a new TB vaccine: Why we are now so close, and why it matters.
A/Prof Angelique Luabeya writes in the Spotlight that the world’s only TB vaccine, BCG is over a century old and offers limited protection. South Africa researchers are leading trials of 3 new candidates, signalling a breakthrough.
Read more
Upcoming seminar: Professors Hatherill & Nemes- TB Vaccines & Immunology Seminar, 19 March 2026 (13:00–14:00)
The South African Immunology Society will host a seminar on 19 March where Professors Mark Hatherill and Elisa Nemes will outline the latest advances in TB vaccines and immunology.
Read more
Narrative history of the South African Tuberculosis Vaccine Initiative
A narrative history of the South African Tuberculosis Vaccine Initiative as told through the voices of the many people who were involved in setting up and sustaining the organisation from 2001 to the present.
Read more
New modelling study shows impact of late stage TB vaccines depends on their ability to prevent infectious, asymptomatic TB
New research, co-authored by SATVI’s Professor Mark Hatherill, has found that the real-world impact of late-stage tuberculosis (TB) vaccines may depend heavily on how well they protect against infectious, asymptomatic TB.
Read more
Vacancies
Professional, administrative and support staff
| Department/School | Faculty | Closing date Sort descending | |
|---|---|---|---|
Data Scientist View advert | View description |
Pathology |
Faculty of Health Sciences |
|
Previous highlights
Professor Mark Hatherill addresses United Nations High-level Meeting on Tuberculosis
SEPTEMBER 2023: Prof Mark Hatherill, addressed the UN High-level Meeting on Tuberculosis, calling for a quantum jump in TB vaccine research and development (R&D) funding, to deliver the transformative tools needed to end the TB pandemic.
Read more
Phase 1b/2a clinical trial in adults of novel TB vaccine candidate MTBVAC shows promising results.
Findings from the IAVI A-050 study, published in Lancet Global Health, demonstrate that vaccination with MTBVAC caused similar or stronger immune responses compared to the BCG vaccine in adults, of MTBVAC were as safe as BCG.
Read more
Upcoming Events
No upcoming events.